Selective PDE4B and PDE4D inhibitors produce distinct behavioral responses to ethanol and GABAergic drugs in mice.

Abstract

Apremilast is a phosphodiesterase (PDE) type 4 inhibitor that is nonselective at subtypes PDE4A-D. It modulates ethanol and GABAergic responses via protein kinase A (PKA) phosphorylation of specific GABAA receptor subunits and has opposite effects on ethanol-induced ataxia in wild-type and GABAA β3-S408/409A knock-in mice. We hypothesized that these different effects are due to preferential actions at different PDE4 subtypes. To test this hypothesis, we compared effects of selective PDE4 inhibitors on responses to ethanol and GABAergic drugs in male and female C57BL/6J mice. The PDE4B inhibitor A33 accelerated recovery from ataxia induced by ethanol and diazepam but did not alter ataxia induced by propofol. The PDE4D inhibitor D159687 accelerated recovery from diazepam-induced ataxia but prolonged recovery from ethanol- and propofol-induced ataxia. A33 shortened, while D159687 prolonged, the sedative-hypnotic effects of ethanol. Both drugs shortened diazepam's sedative-hypnotic effects. The modulatory effects of A33 and D159687 were completely prevented by the PKA inhibitor H89. Only D159687 prevented development of acute functional tolerance to ethanol-induced ataxia. D159687 transiently reduced two-bottle choice drinking in male and female mice that had consumed ethanol for 3 weeks and transiently reduced two-bottle choice, every-other-day drinking in male mice. A33 did not alter ethanol drinking in either procedure. Neither drug altered binge-like ethanol consumption or blood ethanol clearance. Thus, D159687 produced behavioral effects similar to apremilast, although it produced a more transient and smaller reduction in drinking. These results indicate that PDE4D inhibition contributes to apremilast's ability to reduce ethanol drinking, whereas PDE4B inhibition is not involved.

• Authors: Yuri A Blednov, Adriana Da Costa, Sonia Mason, Jody Mayfield, Robert O Messing
• Journal: Neuropharmacology (Neuropharmacology) Vol. 231 Pg. 109508 (06 15 2023) ISSN: 1873-7064 [Electronic] England
• PMID: 36935006 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
• Copyright: Copyright © 2023 Elsevier Ltd. All rights reserved.

Chemical References

• Ethanol
• D159687
• apremilast
• Propofol
• PDE4B inhibitor A33
• Cyclic Nucleotide Phosphodiesterases, Type 4
• Hypnotics and Sedatives
• Phosphodiesterase 4 Inhibitors
• Diazepam
• PDE4B protein, mouse

Topics

• Mice
• Male
• Female
• Animals
• Ethanol
• Propofol
• Mice, Inbred C57BL
• Cyclic Nucleotide Phosphodiesterases, Type 4 (metabolism)
• Hypnotics and Sedatives (pharmacology)
• Phosphodiesterase 4 Inhibitors (pharmacology)
• Ataxia
• Diazepam (pharmacology)